Affordable Alternative? Investigating The Use of Camel's Milk as an Adjunctive Therapy for Insulin-Dependent Diabetes Mellitus

Abstract

Globally, there are approximately 415 million people suffering from diabetes. A significant portion of these individuals require insulin for primary treatment. As the prevalence of diabetes increases, especially in developing countries, there is need for less expensive therapies. As insulin is one of the most expensive liquids in the world, decreasing its demand in impoverished areas is crucial for lowering the levels of morbidity and mortality. The purpose of this structured review was to assess the correlation between drinking camel’s milk and decreased need for exogenous insulin for diabetes management. From our review of the University of Ottawa’s online library database, 5 relevant studies were found. These studies showed a significant correlation between the intake of camel’s milk and the reduction in need of exogenous insulin. From the gathered research, the derived conclusion is that camel’s milk as an adjunctive therapy for insulin-dependent diabetes significantly reduces the required volume of insulin and is a possible method of reducing management costs for diabetics.